Comparative assessment of the effects of dobutamine and levosimendan on right ventricular ejection fraction in patients with biventricular heart failure
Özet
Aim The primary objective of this study was to comparatively assess the effects of levosimendan and dobutamine on RVEF, right ventricular diastolic function, and hormonal balance in patients with biventricular heart failure. The secondary objective was to investigate the relationship between the RVEF and the peak systolic velocity (Sa), an indicator of right ventricular systolic function, as measured by tissue Doppler echocardiography from the tricuspid annulus, and by the tricuspid annular plane systolic excursion (TAPSE). Material and Methods The population of this cross-sectional, single-center, prospective study was comprised of 81 patients, who between December 2019 and January 2022, applied to the study health institution with diagnosis of ADHF. The study sample included 67 biventricular heart failure patients with left ventricular ejection fraction (LVEF) <35% and RVEF <50%, as measured by the ellipsoidal shell model, and who met the other study inclusion criteria. Of these 67 patients, 34 were treated with levosimendan, and 33 were treated with dobutamine. RVEF, LVEF, Sa, peak early (Ea) and peak late (Aa) annular velocities, Ea/Aa ratio, TAPSE, systolic pulmonary artery pressure (SPAP), n-terminal pro-brain natriuretic peptide (NT-pro BNP), and functional capacity (FC) were measured before treatment and at 48 hrs of treatment. The within group pre- and post-treatment differences (?s) of these variables were compared. Results RVEF, SPAP, and BNP, and FC significantly improved in both treatment groups (p<0.05 for all). Sa (p<0.01), TAPSE (p<0.01), LVEF (p<0.01), and Ea/Aa (p<0.05) improved only in the levosimendan group. The pre- and post-treatment ?s for RVEF, LVEF, SPAP, Sa, TAPSE, FC, and Ea/Aa were higher in the levosimendan group than in the dobutamine group (p<0.05 for all). Conclusion Compared to dobutamine, levosimendan produced greater improvement in right ventricular systolic and diastolic function in patients with biventricular heart failure and in need of inotropic therapy support. © 2023 Limited Liability Company KlinMed Consulting. All rights reserved.
Cilt
63Sayı
2Koleksiyonlar
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Unexpected etiology in pericardial effusion: Malignant fibrous histiocytoma: Case report
Hüseyin, Serhat; Yüksel, V.; Gürkan, Selami; Gür, Özcan; Ege, Turan (2013)Although malignant fibrous histiocytoma is the most widely seen malignant soft tis sue tumor in adults, mediastinal localizations are uncommon. In this report, we aimed to present a patient admitted to hospital with ... -
Effects of idiopathic erythrocytosis on the left ventricular diastolic functions and the spectrum of genetic mutations: A case control study
Yeşilaltay, Alpay; Değirmenci, Hasan; Bilgen, Türker; Şirin, Duygu Yaşar; Bayır, Duygu; Değirmenci, Pelin; Turgut, Burhan (Lippincott Williams & Wilkins, 2022)Background: We have aimed at exposing left ventricular diastolic functions and the presence of known genetic mutations for familial erythrocytosis, in patients who exhibit idiopathic erythrocytosis. Methods: Sixty-four ... -
Decrease of left ventricular ejection fraction in severe illness patients due to COVID-19 may improve as the disease resolves
Demirkiran, Aykut; Onar, L. Ç.; Doğan, Mustafa (Turkiye Klinikleri, 2021)Background/aim: Increase in publications supporting myocardial involvement in the COVID-19 disease has led to need to gain insight into the the global burden of heart failure after pandemic. We examined the course of ...